| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.573 | 0.01 | 0.601 | Hypoglycemic | 0.601 0.008 DBMET00289 | DBMET00289 | |
| 0.484 | 0.002 | 0.484 | Carbonic anhydrase stimulant | 0.356 0.003 DBMET00289 | ||
| 0.479 | 0.009 | 0.479 | Diuretic | 0.366 0.015 DBMET00289 | ||
| 0.453 | 0.02 | 0.453 | Cardiotonic | 0.416 0.026 DBMET00289 | ||
| 0.439 | 0.021 | 0.466 | Platelet antagonist | 0.466 0.017 DBMET00289 | DBMET00289 | |
| 0.363 | 0.004 | 0.363 | Carbonic anhydrase XII inhibitor | 0.332 0.004 DBMET00289 | ||
| 0.404 | 0.048 | 0.537 | Antithrombotic | 0.537 0.024 DBMET00289 | DBMET00289 | |
| 0.411 | 0.056 | 0.411 | Calpain 2 inhibitor | 0.344 0.09 DBMET00289 | ||
| 0.356 | 0.008 | 0.356 | Insulin secretagoues | 0.346 0.009 DBMET00289 | ||
| 0.366 | 0.029 | 0.366 | Insulysin inhibitor | 0.318 0.048 DBMET00289 | ||
| 0.354 | 0.023 | 0.354 | Anesthetic general | 0.343 0.025 DBMET00289 | ||
| 0.343 | 0.021 | 0.343 | Platelet adhesion inhibitor | 0.342 0.022 DBMET00289 | ||
| 0.321 | 0.004 | 0.321 | Carbonic anhydrase inhibitor | 0.315 0.004 DBMET00289 | ||
| 0.313 | 0.004 | 0.313 | Carbonic anhydrase IX inhibitor | 0.293 0.005 DBMET00289 | ||
| 0.308 | 0.011 | 0.396 | Aldehyde dehydrogenase inhibitor | 0.396 0.005 DBMET00289 | DBMET00289 | |
| 0.291 | 0.004 | 0.291 | Carbonic anhydrase I inhibitor | 0.268 0.004 DBMET00289 | ||
| 0.266 | 0.004 | 0.266 | Carbonic anhydrase II inhibitor | 0.251 0.005 DBMET00289 | ||
| 0.266 | 0.004 | 0.266 | Electrolyte absorption antagonist | 0.209 0.007 DBMET00289 | ||
| 0.266 | 0.011 | 0.378 | Carbonic anhydrase XV inhibitor | 0.378 0.004 DBMET00289 | DBMET00289 | |
| 0.253 | 0.004 | 0.323 | Carbonic anhydrase V inhibitor | 0.323 0.003 DBMET00289 | DBMET00289 | |
| 0.25 | 0.003 | 0.354 | Thromboxane antagonist | 0.354 0.002 DBMET00289 | DBMET00289 | |
| 0.314 | 0.067 | 0.321 | Sodium/bile acid cotransporter inhibitor | 0.321 0.061 DBMET00289 | DBMET00289 | |
| 0.287 | 0.043 | 0.287 | Gastrin inhibitor | 0.246 0.084 DBMET00289 | ||
| 0.244 | 0.002 | 0.244 | Carbonic anhydrase II stimulant | 0.196 0.002 DBMET00289 | ||
| 0.242 | 0.001 | 0.242 | Carbonic anhydrase I stimulant | 0.206 0.002 DBMET00289 | ||
| 0.238 | 0.003 | 0.35 | Thromboxane A2 antagonist | 0.35 0.002 DBMET00289 | DBMET00289 | |
| 0.276 | 0.042 | 0.276 | Platelet aggregation inhibitor | 0.238 0.057 DBMET00289 | ||
| 0.236 | 0.003 | 0.236 | Potassium channel (ATP-sensitive) blocker | 0.184 0.004 DBMET00289 | ||
| 0.276 | 0.044 | 0.276 | Calpain inhibitor | 0.258 0.057 DBMET00289 | ||
| 0.235 | 0.007 | 0.235 | Metalloproteinase-2 inhibitor | 0.234 0.007 DBMET00289 | ||
| 0.226 | 0.004 | 0.268 | Carbonic anhydrase VA inhibitor | 0.268 0.003 DBMET00289 | DBMET00289 | |
| 0.272 | 0.052 | 0.272 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.227 | 0.01 | 0.359 | Carbonic anhydrase VI inhibitor | 0.359 0.005 DBMET00289 | DBMET00289 | |
| 0.275 | 0.06 | 0.275 | 5 Hydroxytryptamine uptake stimulant | 0.265 0.068 DBMET00289 | ||
| 0.203 | 0.002 | 0.203 | Bombesin 3 receptor antagonist | 0.191 0.002 DBMET00289 | ||
| 0.204 | 0.005 | 0.204 | Carbonic anhydrase VII inhibitor | 0.188 0.005 DBMET00289 | ||
| 0.207 | 0.008 | 0.212 | Metalloproteinase-9 inhibitor | 0.212 0.007 DBMET00289 | DBMET00289 | |
| 0.251 | 0.055 | 0.251 | Neuropeptide Y2 antagonist | 0.214 0.097 DBMET00289 | ||
| 0.207 | 0.014 | 0.207 | Neuropeptide Y antagonist | 0.078 0.062 DBMET00289 | ||
| 0.212 | 0.021 | 0.212 | Nav1.3 sodium channel blocker | 0.19 0.028 DBMET00289 | ||
| 0.242 | 0.057 | 0.247 | Peptidyltransferase inhibitor | 0.247 0.053 DBMET00289 | DBMET00289 | |
| 0.202 | 0.022 | 0.202 | Cathepsin H inhibitor | 0.17 0.034 DBMET00289 | ||
| 0.201 | 0.021 | 0.201 | Aminopeptidase B inhibitor | 0.199 0.021 DBMET00289 | ||
| 0.183 | 0.006 | 0.237 | Prostaglandin E2 antagonist | 0.237 0.005 DBMET00289 | DBMET00289 | |
| 0.178 | 0.004 | 0.331 | Carbonic anhydrase XIV inhibitor | 0.331 0.003 DBMET00289 | DBMET00289 | |
| 0.273 | 0.103 | 0.273 | Thyroid hormone beta antagonist | |||
| 0.269 | 0.112 | 0.269 | Thyroid hormone antagonist | |||
| 0.29 | 0.138 | 0.29 | Beta lactamase inhibitor | |||
| 0.162 | 0.011 | 0.195 | Neutrophil collagenase inhibitor | 0.195 0.008 DBMET00289 | DBMET00289 | |
| 0.196 | 0.046 | 0.301 | Phospholipase C inhibitor | 0.301 0.018 DBMET00289 | DBMET00289 | |
| 0.14 | 0.003 | 0.14 | Potassium channel Kv1.1 blocker | 0.055 0.011 DBMET00289 | ||
| 0.141 | 0.005 | 0.174 | Beta 1 adrenoreceptor antagonist | 0.174 0.004 DBMET00289 | DBMET00289 | |
| 0.179 | 0.043 | 0.179 | Alkaline phosphatase inhibitor | 0.126 0.079 DBMET00289 | ||
| 0.141 | 0.006 | 0.141 | Bcl2 antagonist | 0.13 0.008 DBMET00289 | ||
| 0.138 | 0.004 | 0.141 | Vanilloid 4 agonist | 0.141 0.004 DBMET00289 | DBMET00289 | |
| 0.154 | 0.021 | 0.257 | Carbonic anhydrase XIII inhibitor | 0.257 0.008 DBMET00289 | DBMET00289 | |
| 0.169 | 0.036 | 0.182 | Adenylate cyclase stimulant | 0.182 0.024 DBMET00289 | DBMET00289 | |
| 0.135 | 0.003 | 0.135 | Fructose-1,6-bisphosphatase inhibitor | 0.097 0.004 DBMET00289 | ||
| 0.131 | 0.001 | 0.131 | Carbonic anhydrase IV stimulant | 0.104 0.001 DBMET00289 | ||
| 0.199 | 0.072 | 0.214 | Non-steroidal antiinflammatory agent | 0.214 0.061 DBMET00289 | DBMET00289 | |
| 0.142 | 0.015 | 0.152 | Matrix metalloproteinase inhibitor | 0.152 0.013 DBMET00289 | DBMET00289 | |
| 0.131 | 0.004 | 0.16 | Thromboxane synthase inhibitor | 0.16 0.004 DBMET00289 | DBMET00289 | |
| 0.151 | 0.028 | 0.23 | Carbonic anhydrase III inhibitor | 0.23 0.012 DBMET00289 | DBMET00289 | |
| 0.156 | 0.034 | 0.156 | Sphingosine 1-phosphate receptor 2 antagonist | 0.151 0.039 DBMET00289 | ||
| 0.132 | 0.011 | 0.189 | Carbonic anhydrase VB inhibitor | 0.189 0.005 DBMET00289 | DBMET00289 | |
| 0.126 | 0.006 | 0.159 | Beta 2 adrenoreceptor antagonist | 0.159 0.004 DBMET00289 | DBMET00289 | |
| 0.167 | 0.048 | 0.167 | Nav1.2 sodium channel blocker | 0.108 0.099 DBMET00289 | ||
| 0.13 | 0.015 | 0.13 | Epoxide hydrolase inhibitor | 0.097 0.027 DBMET00289 | ||
| 0.266 | 0.153 | 0.266 | 15-Lipoxygenase inhibitor | |||
| 0.146 | 0.034 | 0.146 | Chemokine receptor antagonist | 0.102 0.061 DBMET00289 | ||
| 0.127 | 0.016 | 0.127 | Thrombin inhibitor | 0.108 0.022 DBMET00289 | ||
| 0.114 | 0.006 | 0.18 | Glucosylceramidase inhibitor | 0.18 0.003 DBMET00289 | DBMET00289 | |
| 0.113 | 0.004 | 0.211 | Prostaglandin EP4 antagonist | 0.211 0.003 DBMET00289 | DBMET00289 | |
| 0.108 | 0.002 | 0.108 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.06 0.003 DBMET00289 | ||
| 0.127 | 0.023 | 0.228 | Adrenaline agonist | 0.228 0.005 DBMET00289 | DBMET00289 | |
| 0.149 | 0.047 | 0.149 | Proteasome inhibitor | 0.146 0.049 DBMET00289 | ||
| 0.112 | 0.01 | 0.112 | Matrix metalloproteinase 1 inhibitor | 0.109 0.011 DBMET00289 | ||
| 0.111 | 0.013 | 0.143 | Beta adrenoreceptor antagonist | 0.143 0.006 DBMET00289 | DBMET00289 | |
| 0.155 | 0.057 | 0.155 | Neuropeptide Y1 antagonist | 0.123 0.117 DBMET00289 | ||
| 0.12 | 0.023 | 0.12 | Glutathione S-transferase inhibitor | 0.116 0.025 DBMET00289 | ||
| 0.103 | 0.006 | 0.103 | Carbonic anhydrase IV inhibitor | 0.103 0.007 DBMET00289 | ||
| 0.106 | 0.012 | 0.106 | Acetyl-CoA transferase inhibitor | 0.071 0.024 DBMET00289 | ||
| 0.117 | 0.023 | 0.117 | Cannabinoid receptor antagonist | 0.062 0.06 DBMET00289 | ||
| 0.199 | 0.105 | 0.199 | Aldehyde oxidase inhibitor | 0.177 0.118 DBMET00289 | ||
| 0.1 | 0.006 | 0.1 | Bcl-xL inhibitor | 0.092 0.008 DBMET00289 | ||
| 0.107 | 0.014 | 0.107 | Cannabinoid CB1 receptor antagonist | 0.068 0.037 DBMET00289 | ||
| 0.098 | 0.006 | 0.098 | Collagenase inhibitor | 0.076 0.008 DBMET00289 | ||
| 0.105 | 0.013 | 0.126 | Beta 3 adrenoreceptor antagonist | 0.126 0.009 DBMET00289 | DBMET00289 | |
| 0.096 | 0.008 | 0.096 | Potassium channel (Inward rectifier) blocker | 0.08 0.013 DBMET00289 | ||
| 0.134 | 0.046 | 0.134 | Interleukin 8 antagonist | 0.1 0.096 DBMET00289 | ||
| 0.092 | 0.004 | 0.092 | Angiotensin AT2 receptor antagonist | 0.087 0.004 DBMET00289 | ||
| 0.092 | 0.006 | 0.096 | Prostaglandin EP3 antagonist | 0.096 0.006 DBMET00289 | DBMET00289 | |
| 0.102 | 0.016 | 0.102 | Trypsin inhibitor | 0.093 0.02 DBMET00289 | ||
| 0.144 | 0.061 | 0.144 | Nav1.6 sodium channel blocker | 0.115 0.104 DBMET00289 | ||
| 0.101 | 0.02 | 0.113 | Sphingosine 1-phosphate receptor antagonist | 0.113 0.015 DBMET00289 | DBMET00289 | |
| 0.091 | 0.01 | 0.091 | Purinergic P2Y antagonist | 0.085 0.011 DBMET00289 | ||
| 0.083 | 0.004 | 0.102 | Angiotensin II receptor antagonist | 0.102 0.003 DBMET00289 | DBMET00289 | |
| 0.2 | 0.121 | 0.2 | MAP kinase kinase 3 inhibitor | |||
| 0.085 | 0.006 | 0.085 | Potassium channel (Inward rectifier) activator | 0.057 0.024 DBMET00289 | ||
| 0.208 | 0.132 | 0.249 | Lipoxygenase inhibitor | 0.249 0.101 DBMET00289 | DBMET00289 | |
| 0.086 | 0.012 | 0.113 | Sphingosine 1-phosphate receptor 1 antagonist | 0.113 0.007 DBMET00289 | DBMET00289 | |
| 0.08 | 0.007 | 0.08 | Potassium channel (ATP-sensitive) activator | 0.053 0.024 DBMET00289 | ||
| 0.073 | 0.004 | 0.082 | Angiotensin AT1 receptor antagonist | 0.082 0.003 DBMET00289 | DBMET00289 | |
| 0.169 | 0.101 | 0.169 | Focal adhesion kinase 2 inhibitor | |||
| 0.097 | 0.03 | 0.097 | Aminopeptidase I inhibitor | 0.089 0.035 DBMET00289 | ||
| 0.1 | 0.034 | 0.1 | Histamine H2 receptor antagonist | |||
| 0.084 | 0.02 | 0.084 | Prostaglandin F2 alpha antagonist | 0.078 0.024 DBMET00289 | ||
| 0.084 | 0.021 | 0.131 | Prostaglandin antagonist | 0.131 0.012 DBMET00289 | DBMET00289 | |
| 0.111 | 0.049 | 0.111 | Factor V inhibitor | 0.109 0.052 DBMET00289 | ||
| 0.093 | 0.032 | 0.093 | GABA aminotransferase inhibitor | 0.081 0.046 DBMET00289 | ||
| 0.112 | 0.051 | 0.138 | Adenylate kinase inhibitor | 0.138 0.032 DBMET00289 | DBMET00289 | |
| 0.065 | 0.005 | 0.065 | Bombesin agonist | 0.036 0.006 DBMET00289 | ||
| 0.073 | 0.015 | 0.111 | Beta 2 adrenoreceptor agonist | 0.111 0.004 DBMET00289 | DBMET00289 | |
| 0.173 | 0.115 | 0.173 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.096 | 0.037 | 0.096 | CC chemokine receptor antagonist | 0.07 0.064 DBMET00289 | ||
| 0.092 | 0.033 | 0.092 | Ca(v)3.1 blocker | |||
| 0.138 | 0.08 | 0.138 | Pregnane X receptor agonist | |||
| 0.144 | 0.086 | 0.169 | Hexokinase inhibitor | 0.169 0.058 DBMET00289 | DBMET00289 | |
| 0.196 | 0.139 | 0.196 | Transcription factor STAT3 inhibitor | 0.179 0.166 DBMET00289 | ||
| 0.08 | 0.024 | 0.085 | Collagenase 3 inhibitor | 0.085 0.022 DBMET00289 | DBMET00289 | |
| 0.117 | 0.065 | 0.128 | Caspase 3 inhibitor | 0.128 0.049 DBMET00289 | DBMET00289 | |
| 0.056 | 0.005 | 0.056 | Bombesin 3 receptor agonist | 0.033 0.005 DBMET00289 | ||
| 0.069 | 0.019 | 0.069 | Metalloproteinase-3 inhibitor | 0.064 0.022 DBMET00289 | ||
| 0.062 | 0.012 | 0.088 | Cytokine production stimulant | 0.088 0.005 DBMET00289 | DBMET00289 | |
| 0.058 | 0.009 | 0.063 | Aggrecanase 1 inhibitor | 0.063 0.008 DBMET00289 | DBMET00289 | |
| 0.128 | 0.079 | 0.128 | CC chemokine 6 receptor antagonist | 0.122 0.108 DBMET00289 | ||
| 0.057 | 0.008 | 0.061 | Integrin alpha2 antagonist | 0.061 0.007 DBMET00289 | DBMET00289 | |
| 0.058 | 0.01 | 0.058 | Acetyl-CoA transferase 1 inhibitor | 0.047 0.02 DBMET00289 | ||
| 0.047 | 0.002 | 0.047 | Angiotensin AT2 receptor agonist | 0.029 0.002 DBMET00289 | ||
| 0.056 | 0.013 | 0.056 | Dihydropteroate synthase inhibitor | 0.047 0.019 DBMET00289 | ||
| 0.133 | 0.091 | 0.134 | Thiol protease inhibitor | 0.134 0.089 DBMET00289 | DBMET00289 | |
| 0.083 | 0.042 | 0.111 | Cathepsin G inhibitor | 0.111 0.029 DBMET00289 | DBMET00289 | |
| 0.053 | 0.013 | 0.096 | Beta adrenoreceptor agonist | 0.096 0.004 DBMET00289 | DBMET00289 | |
| 0.044 | 0.004 | 0.044 | Angiotensin AT1A receptor antagonist | 0.039 0.004 DBMET00289 | ||
| 0.066 | 0.027 | 0.076 | Matrix metalloproteinase (membrane-type) inhibitor | 0.076 0.022 DBMET00289 | DBMET00289 | |
| 0.196 | 0.156 | 0.196 | 12-Lipoxygenase inhibitor | |||
| 0.069 | 0.03 | 0.069 | Potassium channel Kv1.5 blocker | |||
| 0.066 | 0.027 | 0.066 | Neuropeptide Y5 antagonist | |||
| 0.081 | 0.043 | 0.091 | Glutamate dehydrogenase inhibitor | 0.091 0.036 DBMET00289 | DBMET00289 | |
| 0.057 | 0.021 | 0.057 | Bombesin antagonist | 0.053 0.026 DBMET00289 | ||
| 0.043 | 0.006 | 0.043 | Calcium-sensing receptor agonist | 0.04 0.007 DBMET00289 | ||
| 0.038 | 0.003 | 0.042 | Angiotensin AT1B receptor antagonist | 0.042 0.003 DBMET00289 | DBMET00289 | |
| 0.12 | 0.087 | 0.127 | Vanilloid 1 agonist | 0.127 0.072 DBMET00289 | DBMET00289 | |
| 0.081 | 0.047 | 0.081 | Viral attachment inhibitor | 0.076 0.058 DBMET00289 | ||
| 0.037 | 0.005 | 0.098 | Beta 1 adrenoreceptor agonist | 0.098 0.003 DBMET00289 | DBMET00289 | |
| 0.052 | 0.022 | 0.052 | Leukocyte elastase inhibitor | 0.047 0.026 DBMET00289 | ||
| 0.17 | 0.139 | 0.292 | Immunostimulant | 0.292 0.081 DBMET00289 | DBMET00289 | |
| 0.054 | 0.025 | 0.054 | Potassium channel Kv1.3 blocker | 0.043 0.038 DBMET00289 | ||
| 0.158 | 0.129 | 0.158 | Histone acetyltransferase inhibitor | |||
| 0.034 | 0.006 | 0.034 | Protease (Human cytomegalovirus) inhibitor | 0.021 0.017 DBMET00289 | ||
| 0.128 | 0.102 | 0.137 | Anticoagulant | 0.137 0.092 DBMET00289 | DBMET00289 | |
| 0.274 | 0.249 | 0.274 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.032 | 0.008 | 0.032 | Vanilloid 2 agonist | 0.029 0.011 DBMET00289 | ||
| 0.084 | 0.06 | 0.088 | Vanilloid agonist | 0.088 0.05 DBMET00289 | DBMET00289 | |
| 0.114 | 0.092 | 0.114 | Sodium channel blocker | |||
| 0.033 | 0.011 | 0.033 | CXC chemokine 2 receptor antagonist | 0.028 0.016 DBMET00289 | ||
| 0.033 | 0.012 | 0.033 | Epoxide hydrolase 2 inhibitor | |||
| 0.106 | 0.085 | 0.106 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.065 | 0.044 | 0.097 | Interferon inducer | 0.097 0.014 DBMET00289 | DBMET00289 | |
| 0.047 | 0.027 | 0.051 | Macrophage elastase inhibitor | 0.051 0.024 DBMET00289 | DBMET00289 | |
| 0.086 | 0.066 | 0.107 | Aminoacyl-tRNA synthetase inhibitor | 0.107 0.039 DBMET00289 | DBMET00289 | |
| 0.031 | 0.011 | 0.035 | Integrin alpha2beta1 antagonist | 0.035 0.008 DBMET00289 | DBMET00289 | |
| 0.069 | 0.05 | 0.069 | CXC chemokine receptor antagonist | |||
| 0.041 | 0.022 | 0.053 | Farnesoid X receptor agonist | 0.053 0.013 DBMET00289 | DBMET00289 | |
| 0.023 | 0.004 | 0.023 | CC chemokine 10 receptor antagonist | 0.019 0.005 DBMET00289 | ||
| 0.045 | 0.026 | 0.045 | Histamine H2 receptor agonist | |||
| 0.042 | 0.024 | 0.042 | Phenylethanolamine N methyltransferase inhibitor | 0.042 0.025 DBMET00289 | ||
| 0.139 | 0.122 | 0.139 | ATPase inhibitor | |||
| 0.029 | 0.014 | 0.029 | Prostaglandin H2 antagonist | 0.029 0.014 DBMET00289 | ||
| 0.062 | 0.047 | 0.062 | Transcription factor RelA inhibitor | |||
| 0.075 | 0.06 | 0.114 | Interferon agonist | 0.114 0.02 DBMET00289 | DBMET00289 | |
| 0.169 | 0.154 | 0.176 | 5 Hydroxytryptamine release stimulant | 0.176 0.146 DBMET00289 | DBMET00289 | |
| 0.239 | 0.225 | 0.402 | Cyclophilin D inhibitor | 0.402 0.09 DBMET00289 | DBMET00289 | |
| 0.032 | 0.018 | 0.032 | Trypsin II inhibitor | 0.027 0.025 DBMET00289 | ||
| 0.052 | 0.038 | 0.071 | Ornithine carbamoyltransferase inhibitor | 0.071 0.025 DBMET00289 | DBMET00289 | |
| 0.175 | 0.161 | 0.234 | DNA synthesis inhibitor | 0.234 0.079 DBMET00289 | DBMET00289 | |
| 0.099 | 0.086 | 0.099 | Nav1.5 sodium channel blocker | |||
| 0.079 | 0.066 | 0.079 | CC chemokine 5 receptor agonist | |||
| 0.023 | 0.01 | 0.023 | Factor XIII inhibitor | 0.019 0.018 DBMET00289 | ||
| 0.09 | 0.078 | 0.09 | Urease inhibitor | |||
| 0.148 | 0.136 | 0.187 | Insulin sensitizer | 0.187 0.087 DBMET00289 | DBMET00289 | |
| 0.165 | 0.154 | 0.165 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.208 | 0.197 | 0.208 | GABA C receptor rho-3 antagonist | |||
| 0.056 | 0.045 | 0.084 | Prostaglandin EP2 antagonist | 0.084 0.025 DBMET00289 | DBMET00289 | |
| 0.2 | 0.19 | 0.331 | Interleukin 2 agonist | 0.331 0.055 DBMET00289 | DBMET00289 | |
| 0.045 | 0.035 | 0.045 | Glycine transporter inhibitor | |||
| 0.106 | 0.097 | 0.106 | Cyclooxygenase 2 inhibitor | |||
| 0.052 | 0.043 | 0.054 | Epithelial sodium channel blocker | 0.054 0.039 DBMET00289 | DBMET00289 | |
| 0.083 | 0.075 | 0.091 | Thioredoxin inhibitor | 0.091 0.061 DBMET00289 | DBMET00289 | |
| 0.027 | 0.019 | 0.027 | Myristoyl transferase inhibitor | |||
| 0.05 | 0.042 | 0.05 | Neuropeptide agonist | |||
| 0.025 | 0.018 | 0.025 | Complement factor 1s inhibitor | |||
| 0.039 | 0.033 | 0.039 | Oxytocin agonist | |||
| 0.013 | 0.007 | 0.055 | Beta 3 adrenoreceptor agonist | 0.055 0.004 DBMET00289 | DBMET00289 | |
| 0.046 | 0.041 | 0.046 | HCV NS3/NS4A protease inhibitor | |||
| 0.139 | 0.134 | 0.147 | Succinate dehydrogenase inhibitor | 0.147 0.117 DBMET00289 | DBMET00289 | |
| 0.016 | 0.012 | 0.016 | Carbonic anhydrase VIII inhibitor | |||
| 0.016 | 0.012 | 0.016 | Carbonic anhydrase X inhibitor | |||
| 0.021 | 0.018 | 0.021 | Purinergic P2Y12 antagonist | |||
| 0.007 | 0.004 | 0.007 | Bone morphogenic protein 1 inhibitor | 0.007 0.003 DBMET00289 | ||
| 0.048 | 0.045 | 0.048 | Elastase inhibitor | |||
| 0.028 | 0.026 | 0.028 | Epoxide hydrolase 1 inhibitor | |||
| 0.136 | 0.134 | 0.163 | Cyclin-dependent kinase 3 inhibitor | 0.163 0.07 DBMET00289 | DBMET00289 | |
| 0.025 | 0.023 | 0.025 | Bradykinin B1 receptor antagonist | |||
| 0.024 | 0.022 | 0.024 | Acid ceramidase inhibitor | |||
| 0.046 | 0.045 | 0.046 | Alpha 1b adrenoreceptor agonist | |||
| 0.033 | 0.032 | 0.033 | Bradykinin antagonist | |||
| 0.031 | 0.03 | 0.038 | Melatonin receptor 1A agonist | 0.038 0.016 DBMET00289 | DBMET00289 | |
| 0.079 | 0.079 | 0.11 | Triose-phosphate isomerase inhibitor | 0.11 0.039 DBMET00289 | DBMET00289 | |
| 0.013 | 0.017 | 0.023 | Ileal bile acid transport inhibitor | 0.023 0.007 DBMET00289 | DBMET00289 | |
| 0.041 | 0.045 | 0.053 | CC chemokine 4 receptor antagonist | 0.053 0.023 DBMET00289 | DBMET00289 | |
| 0.116 | 0.122 | 0.138 | Phospholipase A2 inhibitor | 0.138 0.089 DBMET00289 | DBMET00289 | |
| 0.077 | 0.086 | 0.11 | Prolactin inhibitor | 0.11 0.046 DBMET00289 | DBMET00289 | |
| 0.18 | 0.19 | 0.224 | Transcription factor NF kappa B inhibitor | 0.224 0.147 DBMET00289 | DBMET00289 | |
| 0.064 | 0.075 | 0.092 | Somatostatin 1 agonist | 0.092 0.039 DBMET00289 | DBMET00289 | |
| 0.018 | 0.033 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.022 0.017 DBMET00289 | DBMET00289 | |
| 0.094 | 0.116 | 0.148 | Toll-Like receptor 2 antagonist | 0.148 0.054 DBMET00289 | DBMET00289 | |
| 0.04 | 0.063 | 0.051 | Argininosuccinate synthase inhibitor | 0.051 0.045 DBMET00289 | DBMET00289 | |
| 0.048 | 0.075 | 0.067 | Lipase inhibitor | 0.067 0.057 DBMET00289 | DBMET00289 | |
| 0.068 | 0.103 | 0.094 | Protease inhibitor | 0.094 0.07 DBMET00289 | DBMET00289 | |
| 0.029 | 0.067 | 0.053 | Ribonucleoside-diphosphate reductase inhibitor | 0.053 0.039 DBMET00289 | DBMET00289 | |
| 0.028 | 0.068 | 0.054 | Ribonucleotide reductase inhibitor | 0.054 0.04 DBMET00289 | DBMET00289 | |
| 0.076 | 0.129 | 0.144 | Amylase inhibitor | 0.144 0.067 DBMET00289 | DBMET00289 | |
| 0.013 | 0.071 | 0.031 | Liver X receptor beta antagonist | 0.031 0.018 DBMET00289 | DBMET00289 | |
| 0.155 | 0.215 | 0.301 | Cholesterol antagonist | 0.301 0.091 DBMET00289 | DBMET00289 | |
| 0.073 | 0.135 | 0.095 | Nav1.4 sodium channel blocker | 0.095 0.084 DBMET00289 | DBMET00289 | |
| 0.031 | 0.117 | 0.06 | Phosphofructokinase-1 inhibitor | 0.06 0.057 DBMET00289 | DBMET00289 | |
| 0.061 | 0.168 | 0.108 | Alkylator | 0.108 0.079 DBMET00289 | DBMET00289 | |
| 0.057 | 0.169 | 0.09 | Transcription factor NF kappa B stimulant | 0.09 0.05 DBMET00289 | DBMET00289 | |
| 0.046 | 0.166 | 0.062 | Prolactin release inhibitor | 0.062 0.045 DBMET00289 | DBMET00289 | |
| 0.024 | 0.146 | 0.051 | Alpha-mannosidase inhibitor | 0.051 0.041 DBMET00289 | DBMET00289 | |
| 0.091 | 0.229 | 0.145 | Hypolipemic | 0.145 0.142 DBMET00289 | DBMET00289 | |
| 0.045 | 0.184 | 0.127 | Bronchodilator | 0.127 0.04 DBMET00289 | DBMET00289 | |
| 0.059 | 0.2 | 0.113 | Alpha-N-acetylglucosaminidase inhibitor | 0.113 0.085 DBMET00289 | DBMET00289 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |